| Trial Identifier: | D9690C00006 |
| Sponsor: | AstraZeneca |
| Start Date: | December 2024 |
| Primary Completion Date: | May 2026 |
| Study Completion Date: | June 2027 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
| Country | Location |
|---|---|
| BE | Leuven, BE, 3000 |
| GB | Birmingham, GB, B15 2GW |
| GB | Cambridge, GB, CB2 0XY |
| GB | London, GB, WC1E 6AG |
| GB | London, GB, NW10 7NS |
| GB | London, GB, E1 1BB |
| IT | Padova, IT, 35121 |
| IT | Roma, IT, 00168 |
| IT | Rozzano, IT, 20089 |
| NL | Amsterdam, NL, 1081 HV |
| NL | Nijmegen, NL, 6525 GA |
| PL | Łódź, PL, 91-495 |
| PL | Poznan, PL, 60-529 |
| PL | Poznań, PL, 60-324 |
| PL | Warszawa, PL, 04-501 |
| PL | Wrocław, PL, 52-210 |
| SE | Linköping, SE, 581 85 |
| SE | Stockholm, SE, 17176 |
| UA | Kyiv, UA, 04210 |
| UA | Kyiv, UA, 02002 |
| UA | Vinnytsia, UA, 21029 |